Joint Spacer Market Forecasts from 2023 to 2028

The joint spacer market was valued at US$2.251 billion in 2021.

The joint-spacer market is anticipated to rise at a steady pace during the projected period. Joint spacer systems are articulating spacers or readymade spacers that come in a variety of sizes and are loaded with antibiotics. These bone cement-based medical devices are used to sustain temporary joint mobility, which enhances functional status. These spacers are the surgical supplies used in the two-stage revision to treat prosthetic joint infection. Joint spacer system sales worldwide have increased, which is attributable to rising orthopedic implant rates and occurrences of prosthetic joint infection.

Market Drivers:

• Increasing research and development

According to the research study, published by the National Institute of Health in December 2020, found that the incidence of knee osteoarthritis varied by country: in the United States, it was 130 per 10,000 people; in the United Kingdom, it was 315; in Japan, it was 525; in Finland, it was 52; in the Netherlands, it was 84; in Norway, it was 33; and in Spain, it was 295 per 10,000 people. As a knee replacement is one of the finest treatments for osteoarthritic disorders, osteoarthritis has a significant influence on the individual patient, causing pain and impairment, as well as on society, which is projected to raise the joint spacer market.

• Product innovations and PJI prevalence

During the anticipated period, the launch of new products is anticipated to drive market expansion. The U.S. joint spacer industry is expanding as a result of manufacturers putting an ever-increasing amount of emphasis on the introduction of prefabricated joint spacers. The prevalence of PJI infection has grown across the nation as a result of the rise in orthopaedic implantation surgeries for the knee, hip, and shoulder. During the anticipated period, it is anticipated that the introduction of an enhanced hip joint spacer to the market would aid in joint spacer market growth.

• Rising orthopedic implantation procedures to foster market progress

Antibiotics are incorporated into articulating or prefabricated joint spacers. There are many different sizes of these spacers. The need for joint spacer devices is projected to increase with the increase in orthopedic implantation procedures. Additionally, it's anticipated that a rise in two-stage revision operations would increase demand for joint spacer devices. Also, the advent of technologically sophisticated spacers is anticipated to promote joint spacer market growth. Additionally, rising medical and healthcare costs can encourage the use of joint spacer devices. These elements contributed to the expansion of the US joint spacer systems market. The development of the joint spacer systems business, however, is expected to be hampered by several substitute items.

• Increased funding from private and public sectors

During the forecast period, the worldwide cervical spa systems market is anticipated to profit from increased investment from the public and private sectors. For instance, in March 2020, the US Food and Drug Administration accepted the regulatory proposal for Tanezumab, a medication used to treat moderate to severe osteoarthritis-related chronic pain. The FDA 510(k) approval for the first patient implant of the 3D-printed CONSTRUX Mini Ti Spacer System was also reported by Orthofix Medical Inc., a reputable supplier of medical products for the spine and extremities, in April 2021.

As Orthofix's first 3D-printed titanium interbody, the COSTRUX Mini Ti cervical spacer with Nanovate TM Technology intends to facilitate anterior cervical discectomy fusion (ACDF) procedures: These positive circumstances will likely cause the joint spacer market growth.

• Rapid technological advancements

During the projected period, nations like the US and Canada are anticipated to contribute the most to joint spacer market growth. Another important factor driving the expansion of the market is the region's healthcare sector's rapid technological progress. Other elements, like an aging population, continued R&D in the sector, and others, are probably going to help the joint spacer industry expand over the assessment period. Growing FDA approvals are predicted to have a significant impact on the development of the joint spacer market throughout the forecast period.

North America is anticipated to dominate the joint spacer market

The rising incidence of osteoarthritis in the region, rising injury & obesity rates, growing product approvals, and favourable investments& initiatives undertaken by the significant market player are the main factors propelling the growth of the North American joint spacer market. Bicycling injuries accounted for nearly 426,000 of all sports and leisure-time injuries in 2020, according to the National Safety Council (NSC). With 230,000 injuries, OHV, moped, and minibike use came in second, while skateboard, scooter, and hoverboard use came in third with 218,000 injuries. It follows that an increase in the need for joint spacers is anticipated as the frequency of injury rises in the US.

Key manufacturers are focusing on product innovation

To spur market expansion, major companies employ a range of tactics, such as alliances, mergers, and acquisitions. For instance, in May 2019, Exactech, a researcher and manufacturer of cutting-edge implants, instruments, and smart technologies for joint replacement surgery, added a new porous-coated implant option to their Truliant Total Knee System. It improves the acclaimed knee system and is built for strength, stability, and efficiency for patients, operating room personnel, and surgeons. Therefore, all of the aforementioned factors are anticipated to fuel joint spacer market expansion throughout the projected time.

Joint Spacer Products

• SynicemTM hip spacer, The Synicem spacer line offers a prefabricated spacer that is ready to use and has the performance qualities required for your two-stage revision operations. Synicem spacers enable revisions of the hip, knee, and shoulder to preserve articular space and help the management of infection.
• Spacer®-G, The prefabricated hip spacer with Gentamicin preloaded is called Spacer®-G. The tool has a stainless steel load-bearing frame with a typical tapered stem. It comes with two distinct stem lengths and three different head sizes (46-54-60mm).

Market Key Developments

• In July 2022, The wearable Arvis, short for augmented reality visualization and information system, was introduced by Enovis as a tool to help surgeons do hip and knee operations.
• In April 2022, Tecres S.p.A. reported the results of its Spacer-K and Vancogenx-Space Knee ATS procedures. The introduction of these devices is probably going to increase the company's options for orthopedic infection management.
• In January 2022, the indications for Smith+Nephew's CORI Surgical System, a portable robotic option for total hip arthroplasty (THA), have been broadened. The goal of Smith and Nephew's RI. HIP NAVIGATION is to provide patient-specific component alignment for THA to increase accuracy and repeatability.

Segmentation:

By Product Type

• Cemented Spacers
• Non-Cemented Spacers
• Resorbable Spacers
• Antibiotic Spacers

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others